SSTR-2a is believed to be an indicator of well-differentiated morphology, and the discriminative significance of the surrogate marker SSTR-2a and p53 have recently been studied in pancreatic NEN with a Ki67-index > 20% [7]. Here, TP53 is linked to pancreatic neuroendocrine neoplasm.